Management of Brain Injury with IV Fluids

First-Line Fluid Therapy

• The American Society of Anesthesiologists recommends isotonic crystalloids, particularly 0.9% saline, as first-line fluid therapy in patients with acute brain injury to reduce mortality and improve neurological prognosis 1, 2
• Isotonic solutions, such as 0.9% NaCl, Plasma-Lyte, and Isofundine, with an osmolarity ranging from 280 to 310 mOsm/L, should be used as first-line fluid therapy in brain injury patients 1
• Isotonic fluids should be administered cautiously to maintain hydration while preventing volume overload during patient transfer 2

Fluids to Avoid

• The Brain Injury Guidelines recommend avoiding hypotonic solutions (< 280 mOsm/L) in patients with acute brain injury due to the risk of inducing cerebral edema 1, 3
• Gelatins, Ringer's lactate, and Ringer's acetate are hypotonic and should be avoided in brain injury patients 2
• A multicenter study reported higher mortality in traumatic brain injury patients treated with hypotonic solutions (Ringer Lactate) compared to isotonic solutions (0.9% NaCl) 1

Colloids and Albumin

• The European Society of Anaesthesiology recommends against the use of synthetic colloids in brain injury patients as they may be associated with worse neurological prognosis 4, 5
• Albumin should be avoided in traumatic brain injury patients as it has been associated with increased mortality, with a relative risk of 1.63 (p = 0.003) in the SAFE study 4, 6

Special Considerations

• Hypertonic saline solutions may be beneficial in specific scenarios, such as combining hemorrhagic shock with severe head trauma and focal neurological signs, due to their osmotic effect 7
• Maintaining euvolemia is crucial, as both hypovolemia and hypervolemia can be detrimental in brain injury patients 6

Monitoring Parameters

• The American College of Surgeons recommends monitoring electrolyte levels regularly, as fluid therapy can lead to electrolyte imbalances, and watching for signs of hyperchloremic metabolic acidosis with prolonged use of 0.9% saline 6

IV Hydration for Neurologic Patients with Brain Edema

First-Line Fluid Selection

• The British Journal of Anaesthesia recommends using alternative isotonic crystalloids such as Plasma-Lyte and buffered isotonic solutions, which have an osmolarity of 280-310 mOsm/L, as they are acceptable alternatives to 0.9% normal saline and may avoid hyperchloremic metabolic acidosis associated with prolonged 0.9% saline use in patients with acute brain injury and cerebral edema 8
• Buffered solutions like Plasma-Lyte do not carry the adverse renal effects seen with high-volume saline administration in neurologic patients with brain edema 8

Critical Fluids to Avoid

• The British Journal of Anaesthesia suggests that albumin must be avoided in traumatic brain injury patients, as the SAFE study showed increased mortality with a relative risk of 1.63, and the ALIAS trials in acute ischemic stroke showed no benefit and a six-fold higher rate of pulmonary edema in albumin-treated patients 8
• Synthetic colloids, such as HES, should not be used in neurologic patients with brain edema as they are associated with worse neurological prognosis and adverse renal effects 8

Volume Management Strategy

• The British Journal of Anaesthesia recommends avoiding hypervolemia in brain-injured patients, as the CENTER-TBI and OzENTER-TBI prospective studies showed higher mortality and worse functional outcomes with higher mean daily fluid balance and positive fluid intake 8
• Neurosurgical patients are frequently intravascularly fluid depleted due to reduced preoperative intake or perioperative osmotic diuretic use, requiring careful volume assessment to maintain euvolemia 8

Monitoring Requirements

• The British Journal of Anaesthesia suggests monitoring cardiovascular status to detect fluid overload or inadequate perfusion in neurologic patients with brain edema 8
• Discontinue therapy if renal, cardiac, or pulmonary status worsens, or if CNS toxicity develops in patients receiving IV hydration for brain edema 8

Fluid Resuscitation in Suspected Brain Injury

Initial Fluid Choice

Fluids to Avoid

Resuscitation Strategy – Volume and Rate

Critical Pitfall – Permissive Hypotension

Maintenance Fluid Management

IV Fluid Management for Cerebral Concussion

Fluid Selection

• 0.9 % normal saline should be used as the sole isotonic crystalloid to maintain euvolemia and prevent hypotension in patients with cerebral concussion. 12
• Real osmolality, not theoretical osmolarity, determines actual fluid shifts across the blood‑brain barrier; solutions that appear isotonic by calculation may behave hypotonic in practice. [12][13]
• The primary goal of fluid therapy is to prevent fluid shifts into damaged cerebral tissue while preserving adequate cerebral perfusion. 12

Fluids to Avoid

• Ringer’s lactate and Ringer’s acetate are contraindicated because their real osmolality is hypotonic and they increase brain water content. [12][13]14
• Synthetic colloids (e.g., hydroxyethyl starches, gelatins) should not be used, as they are associated with worse neurological outcomes and are hypotonic by real‑osmolality measurement. [12][13]
• Hypotonic solutions (e.g., 5 % dextrose) are contraindicated because they lower serum sodium and raise brain water and intracranial pressure. (no citation provided – omitted)

Resuscitation Strategy

• After achieving euvolemia, continue with cautious isotonic fluid administration to maintain hydration while avoiding volume overload. 12
• Switch to maintenance infusion rates rather than aggressive boluses once hemodynamic stability is restored. 12

Critical Pitfalls

• Permissive hypotension is absolutely contraindicated; adequate cerebral perfusion pressure must be maintained to avoid secondary ischemic injury. 12
• In trauma patients with concussion and hypotension, assume hemorrhage until proven otherwise and achieve hemorrhage control before any transfer. [12][13]

Blood Pressure Management

• If hypotension persists after adequate fluid resuscitation, administer small boluses of α‑agonists (e.g., metaraminol) followed by infusion, or initiate norepinephrine via a central line. 12